Fig. 3From: Clinical trials of new drugs for Alzheimer diseaseTrends of phase 1 and phase 2 trials, 2017–2019, according to the event-related categories in ClincalTrials.gov. The percentages of phase 1 and phase 2 trialsBack to article page